A Double-blind, Placebo Controlled First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intra-articular Doses of SAR446959, in Participants With Osteoarthritis of the Knee.

MLA

“A Double-Blind, Placebo Controlled First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intra-Articular Doses of SAR446959, in Participants With Osteoarthritis of the Knee.” Cancer Gene Therapy Week, Dec. 2024, p. 23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=181452758&authtype=sso&custid=ns315887.

APA

A Double-blind, Placebo Controlled First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intra-articular Doses of SAR446959, in Participants With Osteoarthritis of the Knee. (2024). Cancer Gene Therapy Week, 23.

Chicago

“A Double-Blind, Placebo Controlled First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intra-Articular Doses of SAR446959, in Participants With Osteoarthritis of the Knee.” 2024. Cancer Gene Therapy Week, December, 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=181452758&authtype=sso&custid=ns315887.